List of Publications

This webpage lists and provides links to publications that have resulted from research using DHCS data. Publications are posted as they become available.  



  1. Walsh P,  Rothenberg SJ, Bang H.  Safety of ibuprofen in infants younger than six months: A retrospective cohort study.  PLOS. Published on June 28, 2018.
  2. Walsh P, and Rothenberg SJ. Which ICD-9-CM codes should be used for bronchiolitis research? BMC Medical Research Methodology. (2018)18:149. Published on Nov. 22, 2018.


  1. Barnato AE, Moore R, Moore CG, Kohatsu ND, Sudore RL.  Financial Incentives to Increase Advance Care Planning Among Medicaid Beneficiaries: Lessons Learned from Two Pragmatic Randomized Trials.  J Pain Symptom Manage. 2017 Apr 24. pii: S0885-3924(17)30163-X.

  2.  Christina Mangurian, M.D., M.A.S., Maria E. Garcia, M.D., M.P.H., Dean Schillinger, M.D., Eric Vittinghoff, Ph.D., Jennifer M. Creasman, M.S.P.H., Penelope Knapp, M.D., John W. Newcomer, M.D.  Nonpsychiatric Outpatient Care for Adults With Serious Mental Illness in California: Who Is Being Left Behind?  Psychiatric Services July 2017; 68:689–95.

  3. Christina Mangurian, M.D., M.A.S., Monique James, M.D., Melanie Thomas, M.D., M.S., Latoya Frolov, M.D., M.P.H., Nicholas S. Riano, B.A., Eric Vittinghoff, Ph.D., Dean Schillinger, M.D., John W. Newcomer, M.D.  Rates of Cervical Cancer Screening Among Women With Severe Mental Illness in the Public Health System.  American Psychiatric Association.  Print ISSN: 1075-2730 | Online ISSN: 1557-9700.  Published online April 15, 2017.

  4. Christina Mangurian, M.D., M.A.S., Walker Keenan, B.S., John W. Newcomer, M.D., Eric Vittinghoff, Ph.D., Jennifer M. Creasman, M.S.P.H., Dean Schillinger, M.D.   Diabetes Prevalence Among Racial-Ethnic Minority Group Members With Severe Mental Illness Taking Antipsychotics: Double Jeopardy? American Psychiatric Association.  Published online April 17, 2017.

  5. Upadhyay UD, Johns NE, Meckstroth KR, Kerns JL.  Distance Traveled for an Abortion and Source of Care After Abortion. Obstet Gynecol. 2017 Aug 14.

  6. Upadhyay UD, Johns NE, Foster DG.  Distance traveled for Medicaid-covered abortion care in California. BMC Health Serv Res. 2017 Apr 19;17(1):287.


  1. Trager E, Khalili M, Masson C, Vittinghoff E, Creasman J, Mangurian C. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers.  Am J Public Health, 2016; 106: 740-742. 


  1. Mangurian C, Newcomer JW, Vittinghoff E, Creasman JM, Knapp P, Fuentes-Afflick E, Schillinger D.  Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications.  JAMA, Dec 2015; 175 (12): 1977-1980.
  2. Upadhyay U, Desai S, Zlidar V, Weitz TA, Grossman D, Anderson P, Taylor D. Incidence of emergency department visits and complications after abortion. Obstet Gynecol. 2015 Jan; 125(1):175-83. PMID: 25560122.




  1. Cancer Epidemiology Biomarkers Prevcebp.1099.2013; Published Online First December 2, 2013; doi:10.1158/1055-9965.EPI-13-1099 Access to the Indian Health Service Care System is Not Associated with Early Enrollment in Medicaid for American Indian and Alaska Natives with Cancer. Andrea N. Burnett-Hartman, Mark E. Bensink, Kristin Berry, David G. Mummy, Victoria Warren Mears, Carol Korenbrot, and Scott D Ramsey.


  1. Bixby Reproductive Health Brief: Family Planning Provider Education and Training in California. Bixby Center for Global Reproductive Health, University of California, San Francisco. March 2012.
  2. Bixby Reproductive Health Brief: Chlamydia Screening in the Family PACT Program. Bixby Center for Global Reproductive Health, University of California, San Francisco. June 2012.
  3. Chow J, Thiel de Bocanegra H, Hulett D, Park H, Darney P. Comparison of Adherence to Chlamydia Screening Guidelines among Title X Providers and Non-Title X Providers in the California Family Planning, Access, Care, and Treatment (Family PACT) Program. Journal of Women’s Health, 2012 July; 21(0): 1-6.
  4. Park H, Rodriguez M, Hulett D, Darney P,Thiel de Bocanegra H. Long-acting reversible contraception method use among Title X providers and non-Title X providers in California. Contraception. 2012 Nov;86(5):557-61.
  5. Thiel de Bocanegra H, Maguire F, Hulett D, Horsley K, Puffer MJ, Brindis C. Enhancing Service Delivery Through Title X Funding: Findings from California. Perspectives on Sexual and Reproductive Health, 2012 Dec;44(4).


  1. Bixby Reproductive Health Brief: Providing Access to Family Planning through Title X and Medicaid Family Planning Expansion. Bixby Center for Global Reproductive Health, University of California, San Francisco. January 2011.
  2. Fairbrother G, Watring J, Madhavan G, Senderling-McDonald C. A Steep Climb: High Unemployment and Increased Need for Public Assistance in California. Cincinnati: The James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center; 2011.


  1. Fairbrother G, Watring J, Madhavan G.Effects of the Citizenship Documentation Provision of the Deficit Reduction Act of 2005 on Medi-Cal: Overview and Analysis. Cincinnati: The James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center; 2010.


  1. Banta JE, Morrato EH, Lee SWHaviland MG.  Retrospective Analysis of Diabetes Care in California Medicaid Patients with Mental Illness.  J Gen Intern Med.  2009;24(7): 802-8.


  1. Marcus SC, Wan GJ, Zhang HF, Olfson M.  Injury among stimulant-treated youth with ADHD.  J Atten Disord.  2008 Jul;12(1):64-9. Epub 2007 Oct 12.


  1. Olfson M, Marcus SC, Ascher-Svanum H. Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone. Schizophr Bull.  2007 Nov;33(6):1379-87. Epub 2007 Apr 29. 


  1. Olfson M, Marcus SC, Corey-Lisle P, Tuomari AV, Hines P, L'Italien GJ.  Hyperlipidemia following treatment with antipsychotic medicationsAm J Psychiatry.  2006 Oct;163(10):1821-5.                                               


  1. Marcus SC, Wan GJ, Kemner JE, Olfson M.  Continuity of methylphenidate treatment for attention-deficit/ hyperactivity disorderArch Pediatr Adolesc Med. 2005 Jun;159(6):572-8.
Last modified date: 6/26/2019 3:19 PM